Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors
摘要:
3-(4-Bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide (5) was discovered as a new prototype for dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX). Thus, the structure-activity relationships of benzo[1.3.2]dithiazolium ylide 1,1-dioxide skeleton were carried out. The 6-NO2 group played an essential role in the inhibitory activity. In addition, moderate-sized lipophilic substituents at the para-position of the 3-aryl moiety were required for dual COX-2/5-LOX inhibitory activity. Among the identified potent dual inhibitors, 3-(4-tbutylphenyl) derivative 30c (IC50 values of 0.27 mu M and 0.30 mu M against COX-2 and 5-LOX, respectively) and 3-(4-biphenyl) derivative 30f (IC50 values of 0.50 mu M and 0.15 mu M against COX-2 and 5-LOX, respectively) were the most potent dual COX-2/5-LOX inhibitors. Intraperitoneal administration of 30c at 100 mg/kg demonstrated potent acute anti-inflammatory activity. As a result, benzo[1.3.2]dithiazolium ylide 1,1-dioxide represented a novel scaffold for the exploitation in developing dual COX-2/5-LOX inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.
Enantioselective organocatalytic oxidation of ketimine
作者:Shinobu Takizawa、Kenta Kishi、Mohamed Ahmed Abozeid、Kenichi Murai、Hiromichi Fujioka、Hiroaki Sasai
DOI:10.1039/c5ob02042e
日期:——
with promoted the enantioselective organocatalytic oxidation of to afford oxaziridines bearing a tetrasubstituted carbon stereogenic center in high yields with up to 87% ee.
Phosphane-Catalyzed [4+2] Annulation of Allenoates with Ketimines: Synthesis of Sultam-Fused Tetrahydropyridines
作者:Xiang-Yu Chen、Song Ye
DOI:10.1002/ejoc.201200747
日期:2012.10
Cyclic ketimines were successfully used as electrophiles in phosphane-catalyzed [4+2] annulation reactions with ethyl 2-methyl-2,3-butadienoate to give the corresponding highly substituted tetrahydropyridine derivatives in moderate to good yields (55–73 %), and with moderate to excellent regioselectivity.
Catalytic [2+2] and [3+2] cycloaddition reactions of allenoates with cyclic ketimines
作者:Xiang-Yu Chen、Ruo-Chen Lin、Song Ye
DOI:10.1039/c2cc16055b
日期:——
Cyclic ketimines as electrophiles for [2+2] and [3+2] cycloaddition reactions of allenoates have been developed, affording functionalized sultam-fused azetidines and dihydropyrroles, respectively, in good yields with high regioselectivities.
Rh(<scp>iii</scp>)-catalyzed sequential spiroannulation/lactonization of 3-aryl <i>N</i>-sulfonyl ketimines with 4-hydroxy-2-alkynoates by C–H bond activation
作者:S. Prashanth、Chidrawar Ajay、Kommu Nagesh、B. Sridhar、B. V. Subba Reddy
DOI:10.1039/d3nj04312f
日期:2024.4.29
been developed for the synthesis of a highly rigid spirobenzosultam lactones in good yields with high regioselectivity by means of aromatic ortho-C–H bondactivation/functionalization of 3-aryl N-sulfonyl ketimines with 4-hydroxy-2-alkynoates. The reaction proceeds through a cascade of C–H activation followed by spiroannulation and lactonization. In this approach, two C–C and C–O bonds are formed in a
Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors
3-(4-Bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide (5) was discovered as a new prototype for dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX). Thus, the structure-activity relationships of benzo[1.3.2]dithiazolium ylide 1,1-dioxide skeleton were carried out. The 6-NO2 group played an essential role in the inhibitory activity. In addition, moderate-sized lipophilic substituents at the para-position of the 3-aryl moiety were required for dual COX-2/5-LOX inhibitory activity. Among the identified potent dual inhibitors, 3-(4-tbutylphenyl) derivative 30c (IC50 values of 0.27 mu M and 0.30 mu M against COX-2 and 5-LOX, respectively) and 3-(4-biphenyl) derivative 30f (IC50 values of 0.50 mu M and 0.15 mu M against COX-2 and 5-LOX, respectively) were the most potent dual COX-2/5-LOX inhibitors. Intraperitoneal administration of 30c at 100 mg/kg demonstrated potent acute anti-inflammatory activity. As a result, benzo[1.3.2]dithiazolium ylide 1,1-dioxide represented a novel scaffold for the exploitation in developing dual COX-2/5-LOX inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.